Neurochemical Research

, Volume 7, Issue 4, pp 373–385 | Cite as

Accumulation, elimination, release and metabolism of pipecolic acid in the mouse brain following intraventricular injection

  • H. Nishio
  • E. Giacobini
  • J. Ortiz
Original Articles


Following i.c.v. (intracerebral ventricular) injections ofd,l-[3H]pipecolic acid (PA), it is reabsorbed from the ventricles and redistributed to various brain regions. The highest accumulation is found in three brain regions ipsilateral to the injection site, hippocampus, neocortex, striatum, and in the diencephalon. Following preloading in vivo, the radioactivity is released from hippocampus slices in the perfusion medium after depolarization induced by high K+. During perfusion with a Ca++ free medium containing EGTA, a significant reduction of release is observed.

The radioactivity ofd,l-[3H]PA in the brain shows a more rapid phase of decrease from 0 to 2 hours and a slower phase from 2 to 5 hours. At 5 hours, only 28% radioactivity, represented mainly by PA, is left in the brain. Kidney secretion represents the major route of elimination of the injected PA. The presence of α-aminoadipic acid both in brain and urine was observed. Probenecid (200 mg/kg) significantly increases the accumulation of i.c.v. injectedd,l-[3H]PA in brain and kidney. The presence of a regional accumulation of PA in certain brain regions, its metabolism in brain, its enhanced retention following probenecid administration and its Ca++ dependent release following high K+ stimulation, all constitute indirect evidence for a neuronal localization of this brain endogenous iminoacid.


Brain Region EGTA Mouse Brain Injection Site High Accumulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schmidt-Glenewinkel, T., Nomura, Y., andGiacobini, E. 1977. The conversion of lysine into piperidine, cadaverine, and pipecolic acid in the brain and other organs of the mouse. Neurochem. Res. 2:619–637.Google Scholar
  2. 2.
    Giacobini, E., Nomura, Y., andSchmidt-Glenewinkel, T. 1980. Pipecolic acid: Origin, biosynthesis and metabolism in the brain. Cell. Molec. Biol. 26:135–146.Google Scholar
  3. 3.
    Nishio, H., Ortiz, J., andGiacobini, E. 1981. Accumulation and metabolism of pipecolic acid in the brain and other organs of the mouse. Neurochem. Res. 6:1235–1245.Google Scholar
  4. 4.
    Rothstein, M., andMiller, L. L. 1954. The metabolism of L-lysine-6-14C. J. Biol. Chem. 206:243–253.PubMedGoogle Scholar
  5. 5.
    Nishio, H., andGiacobini, E. 1981. Brain uptake of pipecolic acid, amino acids and amines following intracarotic injection in the mouse. Neurochem. Res. 6:835–845.PubMedGoogle Scholar
  6. 6.
    Burgstahler, A. W., andAiman, C. E. 1960. A direct synthesis ofd,l-baikiain. J. Org. Chem. 25:489–492.Google Scholar
  7. 7.
    Sidman, R. L., Angevine, J. B., Jr. andPierce, E. T. 1971. Atlas of the mouse brain and spinal cord. Cambridge, Mass.: Harvard Univ. Press.Google Scholar
  8. 8.
    Nomura, Y., Okuma, Y., Segawa, T., Schmidt-Glenewinkel, T., andGiacobini, E. 1979. A calcium-dependent, high potassium-induced release of pipecolic acid from rat brain slices. J. Neurochem. 33 (3):803–805.PubMedGoogle Scholar
  9. 9.
    Schmidt-Glenewinkel, T., Giacobini, E., Nomura, Y., Okuma, Y., andSegawa, T. 1978. Presence, metabolism and uptake of pipecolic acid in the mouse brain. 2nd Meet. Eur. Soc. Neurochem., Abst. 618.Google Scholar
  10. 10.
    Nomura, Y., Schmidt-Glenewinkel, T., andGiacobini, E. 1978. In vitro formation of piperidine, cadaverine and pipecolic acid in chick and mouse brain during development. Dev. Neurosci. 1:239–249.Google Scholar
  11. 11.
    Chang, Y. F. 1976. Pipecolic pathway: The major lysine metabolic route in the rat brain. Biochem. Biophys. Res. Commun. 69:174–180.PubMedGoogle Scholar
  12. 12.
    Chang, Y. F. 1978. Lysine metabolism in the rat brain: The pipecolic acid-forming pathway. J. Neurochem. 30:347–354.PubMedGoogle Scholar
  13. 13.
    Nomura, Y., Schmidt-Glenewinkel, T., andGiacobini, E. 1980. Uptake of piperidine and pipecolic acid by synaptosomes from mouse brain. Neurochem. Res. 5:1163–1173.PubMedGoogle Scholar
  14. 14.
    Oldendorf, W. H. 1971. Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Amer. J. Physiol. 221:1629–1639.PubMedGoogle Scholar
  15. 15.
    Okuma, Y., Nomura, Y., andSegawa, T. 1979. The effect of piperidine and pipecolic acid on high potassium-induced release of noradrenaline, serotonin and GABA from rat brain slices. J. Pharm. Dyn. 2:261–265.Google Scholar
  16. 16.
    Nomura, Y., Okuma, Y., Segawa, T., Schmidt-Glenewinkel, T., andGiacobini, E. 1981. Comparison of the synaptosomal and glial uptake of pipecolic acid and GABA in the rat brain. Neurochem. Res. 6:391–400.PubMedGoogle Scholar
  17. 17.
    Garweg, G., von Rehren, D., andHintze, U. 1980. L-pipecolate formation in the mammalian brain. Regional distribution of Δ1-pyrroline-2-carboxylate reductase activity. J. Neurochem. 35:616–621.PubMedGoogle Scholar
  18. 18.
    Olney, J. W., de Gubareff, T., andCollins, J. F. 1980. Stereospecificity of the gliotoxic and anti-neurotoxic actions of alpha-aminoadipate. Neurosci. Lett. 19:277–282.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • H. Nishio
    • 1
  • E. Giacobini
    • 1
  • J. Ortiz
    • 1
  1. 1.Laboratory of Neuropsychopharmacology Department of Biobehavioral SciencesUniversity of ConnecticutStorrs

Personalised recommendations